GRP
KRYS icon

Global Retirement Partners’s Krystal Biotech KRYS Stock Holding History

Global Retirement Partners’s Portfolio KRYS Stock Details KRYS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q4 		$39.4K Buy
160
+142
+789% +$29.9K ﹤0.01% 2490
2025
Q3 		$3.18K Buy
18
+7
+64% +$1.05K ﹤0.01% 3148
2025
Q2 		$1.51K Buy
+11
New +$1.62K ﹤0.01% 3333
2023
Q2 		– Sell
-125
Closed -$10.5K – 3227
2023
Q1 		$10.5K Hold
125
– – ﹤0.01% 1909
2022
Q4 		$9.9K Hold
125
– – ﹤0.01% 1786
2022
Q3 		$10K Hold
125
– – ﹤0.01% 1687
2022
Q2 		$8K Hold
125
– – ﹤0.01% 1734
2022
Q1 		$7K Buy
+125
New +$7.8K ﹤0.01% 1777
2021
Q4 		– Sell
-125
Closed -$7K – 1100
2021
Q3 		$7K Hold
125
– – ﹤0.01% 1525
2021
Q2 		$9K Sell
125
-75
-38% -$5.24K ﹤0.01% 1401
2021
Q1 		$15K Buy
200
+75
+60% +$5.45K ﹤0.01% 1187
2020
Q4 		$8K Buy
+125
New +$6.24K ﹤0.01% 1323

Other funds holding KRYS

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
ACA
Avoro Capital Advisors New York $10.2B AUM 149.19% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
SCM
Soleus Capital Management Greenwich, Connecticut $2.47B AUM 115.63% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
RG
Redmile Group San Francisco, California $1.51B AUM 164.17% 1-Year Est. Return
HRCM
Hood River Capital Management Palm Beach Gardens, Florida $9.98B AUM 145.42% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Global Retirement Partners's KRYS Position: Q4 2025 in Review

Global Retirement Partners increased its Krystal Biotech (KRYS) stake by 789% in Q4 2025, buying an estimated $29.9K and bringing the position to 160 shares worth $39.4K. The position accounts for ﹤0.01% of the portfolio, ranked #2490.

Global Retirement Partners first reported a position in KRYS in Q4 2020 and has held it in 12 quarters since. 334 funds tracked by Wall St. Rank hold KRYS as of Q4 2025.

  • Global Retirement Partners held 160 shares of Krystal Biotech worth $39.4K as of Q4 2025.
  • Global Retirement Partners bought 142 Krystal Biotech shares in Q4 2025, an estimated $29.9K.
  • Krystal Biotech made up ﹤0.01% of Global Retirement Partners's portfolio in Q4 2025, its #2490 holding.
  • Global Retirement Partners first reported a position in Krystal Biotech in Q4 2020 and has held it in 12 quarters since.
  • 334 funds tracked by Wall St. Rank held Krystal Biotech as of Q4 2025.

Based on Global Retirement Partners's 13F filing for Q4 2025, filed 6 Feb 2026.